It was a year which began for pharmacy in discussion of the fate of codeine, staff pay issues and a review which threatened to destabilise the community pharmacy model And …

New Ministers appointed to health, business portfolios Some new faces will be occupying ministerial positions in portfolios of relevance to community pharmacy after Prime Minister Malcolm Turnbull announced his Cabinet …

AJP editor Chris Brooker reflects on what the rise of the super banner group may mean to community pharmacy Crosby, Stills and Nash (and Young, though he was better than …

Nine key revelations on what community pharmacists think from the 2017 UTS Pharmacy Barometer Half of all pharmacists believe that the growth of online retailers has had a negative impact …

Lynn Weekes to leave NPS after two decades at the helm The Board of NPS MedicineWise has announced that Dr Lynn Weekes AM has resigned as the organisation’s CEO after …

Opinions and concerns of pharmacy owners and employees now more divergent than ever before There is now a wider gulf in the views of pharmacy owners and employee pharmacists than …

Worried about the level of your caffeine intake? Well, new research has indicated that 3-4 cups per day may be doing more good than harm, except during pregnancy UK researchers …

Wholesalers forced to act in the wake of direct distribution defections The recent moves by manufacturers AstraZeneca and Amgen to a direct distribution model are being blamed for driving full-line …

A roundup of research from the recent SHPA Medicines Management 2017 conference, including evidence of poor discharge prescribing of opioids    Guidelines are being developed by a local health district …

Study reveals widespread support for including the indication on scripts and medication labels, but concerns have been raised over workload and privacy Adding the indication or purpose of the medication …

Same-sex marriage debate puts the kibosh on annual Guild dinner The Pharmacy Guild of Australia’s annual Parliament House dinner has become an unwitting collateral victim of the debate over same …

The manufacturer of testosterone replacement therapy Testogel says it will work with health professionals to fill the void left by the withdrawal of competitor product, Axiron Eli Lilly has this …